A NOVEL POINT-OF-CARE REJECTION AND IMMUNOSUPPRESSION MONITORING ASSAY (PRIMA) FOR VASCULARIZED COMPOSITE ALLOTRANSPLANTATION (VCA)

Intelligent Optical Systems, Inc., Torrance CA

Investigators